Extracellular Vesicle Research Funding Opportunities

Extracellular Vesicle NIH Funding Opportunities

Title FOA Number Institute Start Date End Date
Program to Assess the Rigor and Reproducibility ofExtracellularVesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) PAR-20-053 NCI 11/12/2019 01/07/2023 R01
Trans-Agency Blood-Brain Interface Program (R61/R33 – Clinical Trials Not Allowed) RFA-HL-20-021 NHLBI 09/03/2019 12/21/2021 R61/R33
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) PA-19-237 NIAID 04/03/2019 05/07/2022 R21
Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) RFA-AG-21-002 NIA 12/17/2019 06/17/2020 R01
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) RFA-DK-19-024 NIDDK 01/02/2020 04/01/2020 U01
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) RFA-CA-19-032 NCI 01/24/2019 08/03/2020 R01
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-19-356 NCI 08/28/2019 07/20/2022 R21
Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders NOT-DA-20-031 NIDA 02/06/2020 01/07/2023 Admin Supp, R01, R03, R21, R21/R33
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) RFA-CA-19-053 NCI 09/05/2019 06/23/2021 P50
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) RFA-CA-19-050 NCI 09/05/2019 06/23/2021 U01
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) RFA-CA-19-049 NCI 09/05/2019 06/23/2021 R01
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) RFA-CA-19-051 NCI 09/06/2019 06/23/2021 U54
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) RFA-CA-19-052 NCI 09/05/2019 06/23/2021 P01
Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) RFA-HD-21-005 NICHD 03/19/2020 07/30/2020 R01
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) PAR-19-372 NIMHD 09/10/2019 11/08/2022 R01
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-19-363 NCI 09/05/2019 05/07/2021 R01
Notice of Special Interest: High-Priority Research Topics for PAR-19-071 NOT-AG-19-007 NIA 03/05/2019 N/A N/A
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 NCI 12/17/2018 01/07/2022 R01
0